Skip to main content
Top
Published in: European Journal of Nutrition 2/2016

01-03-2016 | Original Contribution

Houttuynia cordata aqueous extract attenuated glycative and oxidative stress in heart and kidney of diabetic mice

Authors: Cheng-chin Hsu, Hui-ting Yang, Jing-jing Ho, Mei-chin Yin, Jen-ying Hsu

Published in: European Journal of Nutrition | Issue 2/2016

Login to get access

Abstract

Purpose

The anti-glycative and anti-oxidative effects from Houttuynia cordata leaves aqueous extract (HCAE) in heart and kidney of diabetic mice were examined.

Methods

HCAE, at 1 or 2 %, was supplied in drinking water for 8 weeks. Plasma glucose and blood urea nitrogen (BUN) levels and creatine phosphokinase (CPK) activity were measured. The production of oxidative and inflammatory factors was determined. Activity and protein expression of associated enzymes or regulators were analyzed.

Results

HCAE intake at both doses lowered plasma glucose and BUN levels, and CPK activity and also restored creatinine clearance rate in diabetic mice. HCAE intake, only at 2 %, retained plasma insulin levels (P < 0.05). HCAE reduced reactive oxygen species, protein carbonyl, interleukin-6, tumor necrosis factor-alpha, N ε -(carboxymethyl)-lysine, pentosidine and fructose levels, and reserved glutathione content in heart and kidney of diabetic mice (P < 0.05). Diabetes enhanced aldose reductase (AR) activity and protein expression in heart and kidney (P < 0.05). HCAE intake at both doses decreased renal AR activity and protein expression, but only at 2 % lowered cardiac AR activity and protein expression (P < 0.05). Diabetes increased protein expression of RAGE, p47phox and gp91phox, nuclear factor kappa-B (NF-κB) p50, NF-κB p65 and mitogen-activated protein kinase in heart and kidney (P < 0.05). HCAE intake only at 2 % limited RAGE expression, but at 1 and 2 % downregulated p47phox, NF-κB p65 and p-p38 expression in these organs (P < 0.05).

Conclusions

These findings suggest that Houttuynia cordata leaves aqueous extract could ameliorate cardiac and renal injury under diabetic condition.
Literature
1.
go back to reference Dunlop M (2000) Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl 77:S3–S12CrossRef Dunlop M (2000) Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl 77:S3–S12CrossRef
2.
go back to reference Chung SS, Ho EC, Lam KS, Chung SK (2003) Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 14:S233–S236CrossRef Chung SS, Ho EC, Lam KS, Chung SK (2003) Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 14:S233–S236CrossRef
3.
go back to reference Peyroux J, Sternberg M (2006) Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes. Pathol Biol 54:405–419CrossRef Peyroux J, Sternberg M (2006) Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes. Pathol Biol 54:405–419CrossRef
4.
go back to reference Vlassara H, Striker GE (2013) Advanced glycation endproducts in diabetes and diabetic complications. Endocrinol Metab Clin North Am 42:697–719CrossRef Vlassara H, Striker GE (2013) Advanced glycation endproducts in diabetes and diabetic complications. Endocrinol Metab Clin North Am 42:697–719CrossRef
5.
go back to reference Hirata K, Kubo K (2004) Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes. Endocr J 51:537–544CrossRef Hirata K, Kubo K (2004) Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes. Endocr J 51:537–544CrossRef
6.
go back to reference Ghanem AA, Elewa A, Arafa LF (2011) Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy. Eur J Ophthalmol 21:48–54CrossRef Ghanem AA, Elewa A, Arafa LF (2011) Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy. Eur J Ophthalmol 21:48–54CrossRef
7.
go back to reference Barlovic DP, Thomas MC, Jandeleit-Dahm K (2010) Cardiovascular disease: what’s all the AGE/RAGE about? Cardiovasc Hematol Disord Drug Targets 10:7–15CrossRef Barlovic DP, Thomas MC, Jandeleit-Dahm K (2010) Cardiovascular disease: what’s all the AGE/RAGE about? Cardiovasc Hematol Disord Drug Targets 10:7–15CrossRef
8.
go back to reference Xie J, Méndez JD, Méndez-Valenzuela V, Aguilar-Hernández MM (2013) Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signal 25:2185–2197CrossRef Xie J, Méndez JD, Méndez-Valenzuela V, Aguilar-Hernández MM (2013) Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signal 25:2185–2197CrossRef
9.
go back to reference Meng J, Leung KS, Jiang Z, Dong X, Zhao Z, Xu LJ (2005) Establishment of HPLC-DAD-MS fingerprint of fresh Houttuynia cordata. Chem Pharm Bull 53:1604–1609CrossRef Meng J, Leung KS, Jiang Z, Dong X, Zhao Z, Xu LJ (2005) Establishment of HPLC-DAD-MS fingerprint of fresh Houttuynia cordata. Chem Pharm Bull 53:1604–1609CrossRef
10.
go back to reference Wang F, Lu F, Xu L (2007) Effects of Houttuynia cordata thumb on expression of BMP-7 and TGF-beta1 in the renal tissues of diabetic rats. J Tradit Chin Med 27:220–225 Wang F, Lu F, Xu L (2007) Effects of Houttuynia cordata thumb on expression of BMP-7 and TGF-beta1 in the renal tissues of diabetic rats. J Tradit Chin Med 27:220–225
11.
go back to reference Kumar M, Prasad SK, Krishnamurthy S, Hemalatha S (2014) Antihyperglycemic activity of Houttuynia cordata Thunb. in streptozotocin-induced diabetic rats. Adv Pharm Sci 2014:809438 Kumar M, Prasad SK, Krishnamurthy S, Hemalatha S (2014) Antihyperglycemic activity of Houttuynia cordata Thunb. in streptozotocin-induced diabetic rats. Adv Pharm Sci 2014:809438
12.
go back to reference Guan JZ, Wang JJ, Cheng ZH, Liu Y, Li ZY (2012) Cytomixis and meiotic abnormalities during microsporogenesis are responsible for male sterility and chromosome variations in Houttuynia cordata. Genet Mol Res 11:121–130CrossRef Guan JZ, Wang JJ, Cheng ZH, Liu Y, Li ZY (2012) Cytomixis and meiotic abnormalities during microsporogenesis are responsible for male sterility and chromosome variations in Houttuynia cordata. Genet Mol Res 11:121–130CrossRef
13.
go back to reference Lin MC, Hsu PC, Yin MC (2013) Protective effects of Houttuynia cordata aqueous extract in mice consuming a high saturated fat diet. Food Funct 4:322–327CrossRef Lin MC, Hsu PC, Yin MC (2013) Protective effects of Houttuynia cordata aqueous extract in mice consuming a high saturated fat diet. Food Funct 4:322–327CrossRef
14.
go back to reference Singleton VL, Orthofer R, Lamuela-Raventos RM (1999) Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin Ciocalteu reagent. Methods Enzymol 299:152–178CrossRef Singleton VL, Orthofer R, Lamuela-Raventos RM (1999) Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin Ciocalteu reagent. Methods Enzymol 299:152–178CrossRef
15.
go back to reference Zhishen J, Mengcheng T, Jianming W (1999) The determination of flavonoid content in mulberry and their scavenging effects on superoxide radicals. Food Chem 64:555–559CrossRef Zhishen J, Mengcheng T, Jianming W (1999) The determination of flavonoid content in mulberry and their scavenging effects on superoxide radicals. Food Chem 64:555–559CrossRef
16.
go back to reference Miyata T, Taneda S, Kawai R, Ueda Y, Horiuchi S, Hara M, Maeda K, Monnier VM (1996) Identification of pentosidine as a native structure for advanced glycation end products in β-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 93:2353–2358CrossRef Miyata T, Taneda S, Kawai R, Ueda Y, Horiuchi S, Hara M, Maeda K, Monnier VM (1996) Identification of pentosidine as a native structure for advanced glycation end products in β-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 93:2353–2358CrossRef
17.
go back to reference Guerrant G, Moss CW (1984) Determination of monosaccharides as aldononitrile, O-methyloxime, alditol, and cyclitol acetate derivatives by gas chromatography. Anal Chem 56:633–638CrossRef Guerrant G, Moss CW (1984) Determination of monosaccharides as aldononitrile, O-methyloxime, alditol, and cyclitol acetate derivatives by gas chromatography. Anal Chem 56:633–638CrossRef
18.
go back to reference Nishinaka T, Yabe-Nishimura C (2001) EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress. Free Radic Biol Med 31:205–216CrossRef Nishinaka T, Yabe-Nishimura C (2001) EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress. Free Radic Biol Med 31:205–216CrossRef
19.
go back to reference Fiorentino TV, Prioletta A, Zuo P, Folli F (2013) Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des 19:5695–5703CrossRef Fiorentino TV, Prioletta A, Zuo P, Folli F (2013) Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des 19:5695–5703CrossRef
20.
go back to reference Palomer X, Salvadó L, Barroso E, Vázquez-Carrera M (2013) An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Int J Cardiol 168:3160–3172CrossRef Palomer X, Salvadó L, Barroso E, Vázquez-Carrera M (2013) An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Int J Cardiol 168:3160–3172CrossRef
21.
go back to reference Gorin Y, Block K (2013) Nox as a target for diabetic complications. Clin Sci 125:361–382CrossRef Gorin Y, Block K (2013) Nox as a target for diabetic complications. Clin Sci 125:361–382CrossRef
22.
go back to reference Teshima Y, Takahashi N, Nishio S, Saito S, Kondo H, Fukui A, Aoki K, Yufu K, Nakagawa M, Saikawa T (2014) Production of reactive oxygen species in the diabetic heart. Roles of mitochondria and NADPH oxidase. Circ J 78:300–306CrossRef Teshima Y, Takahashi N, Nishio S, Saito S, Kondo H, Fukui A, Aoki K, Yufu K, Nakagawa M, Saikawa T (2014) Production of reactive oxygen species in the diabetic heart. Roles of mitochondria and NADPH oxidase. Circ J 78:300–306CrossRef
23.
go back to reference Mukherjee TK, Mukhopadhyay S, Hoidal JR (2005) The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. Biochim Biophys Acta 1744:213–223CrossRef Mukherjee TK, Mukhopadhyay S, Hoidal JR (2005) The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. Biochim Biophys Acta 1744:213–223CrossRef
24.
go back to reference Harijith A, Ebenezer DL, Natarajan V (2014) Reactive oxygen species at the crossroads of inflammasome and inflammation. Front Physiol 5:352CrossRef Harijith A, Ebenezer DL, Natarajan V (2014) Reactive oxygen species at the crossroads of inflammasome and inflammation. Front Physiol 5:352CrossRef
25.
go back to reference Lieuw-A-Fa ML, van Hinsbergh VW, Teerlink T, Barto R, Twisk J, Stehouwer CD, Schalkwijk CG (2004) Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction. Nephrol Dial Transplant 19:631–636CrossRef Lieuw-A-Fa ML, van Hinsbergh VW, Teerlink T, Barto R, Twisk J, Stehouwer CD, Schalkwijk CG (2004) Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction. Nephrol Dial Transplant 19:631–636CrossRef
26.
go back to reference Chao PC, Huang CN, Hsu CC, Yin MC, Guo YR (2010) Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1α and MCP-1 levels in type 2 diabetic patients. Eur J Nutr 49:429–434CrossRef Chao PC, Huang CN, Hsu CC, Yin MC, Guo YR (2010) Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1α and MCP-1 levels in type 2 diabetic patients. Eur J Nutr 49:429–434CrossRef
27.
go back to reference Kaneko M, Bucciarelli L, Hwang YC, Lee L, Yan SF, Schmidt AM, Ramasamy R (2005) Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury. Annu N Y Acad Sci 1043:702–709CrossRef Kaneko M, Bucciarelli L, Hwang YC, Lee L, Yan SF, Schmidt AM, Ramasamy R (2005) Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury. Annu N Y Acad Sci 1043:702–709CrossRef
28.
go back to reference Obrosova IG, Kador PF (2011) Aldose reductase/polyol inhibitors for diabetic retinopathy. Curr Pharm Biotechnol 12:373–385CrossRef Obrosova IG, Kador PF (2011) Aldose reductase/polyol inhibitors for diabetic retinopathy. Curr Pharm Biotechnol 12:373–385CrossRef
29.
go back to reference Shi L, Yu X, Yang H, Wu X (2013) Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways. PLoS ONE 8:e66781CrossRef Shi L, Yu X, Yang H, Wu X (2013) Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways. PLoS ONE 8:e66781CrossRef
30.
go back to reference Fukami K, Yamagishi S, Okuda S (2014) Role of AGEs-RAGE system in cardiovascular disease. Curr Pharm Des 20:2395–2402CrossRef Fukami K, Yamagishi S, Okuda S (2014) Role of AGEs-RAGE system in cardiovascular disease. Curr Pharm Des 20:2395–2402CrossRef
31.
go back to reference Kim JM, Lee EK, Kim DH, Yu BP, Chung HY (2010) Kaempferol modulates pro-inflammatory NF-kappaB activation by suppressing advanced glycation endproducts-induced NADPH oxidase. Age 32:197–208CrossRef Kim JM, Lee EK, Kim DH, Yu BP, Chung HY (2010) Kaempferol modulates pro-inflammatory NF-kappaB activation by suppressing advanced glycation endproducts-induced NADPH oxidase. Age 32:197–208CrossRef
32.
go back to reference Zang Y, Sato H, Igarashi K (2011) Anti-diabetic effects of a kaempferol glycoside-rich fraction from unripe soybean (Edamame, Glycine max L. Merrill. ‘Jindai’) leaves on KK-A(y) mice. Biosci Biotechnol Biochem 75:1677–1684CrossRef Zang Y, Sato H, Igarashi K (2011) Anti-diabetic effects of a kaempferol glycoside-rich fraction from unripe soybean (Edamame, Glycine max L. Merrill. ‘Jindai’) leaves on KK-A(y) mice. Biosci Biotechnol Biochem 75:1677–1684CrossRef
33.
go back to reference Ramar M, Manikandan B, Raman T, Priyadarsini A, Palanisamy S, Velayudam M, Munusamy A, Marimuthu PN, Vaseeharan B (2012) Protective effect of ferulic acid and resveratrol against alloxan-induced diabetes in mice. Eur J Pharmacol 690:226–235CrossRef Ramar M, Manikandan B, Raman T, Priyadarsini A, Palanisamy S, Velayudam M, Munusamy A, Marimuthu PN, Vaseeharan B (2012) Protective effect of ferulic acid and resveratrol against alloxan-induced diabetes in mice. Eur J Pharmacol 690:226–235CrossRef
34.
go back to reference Umadevi S, Gopi V, Elangovan V (2014) Regulatory mechanism of gallic acid against advanced glycation end products induced cardiac remodeling in experimental rats. Chem Biol Interact 208:28–36CrossRef Umadevi S, Gopi V, Elangovan V (2014) Regulatory mechanism of gallic acid against advanced glycation end products induced cardiac remodeling in experimental rats. Chem Biol Interact 208:28–36CrossRef
Metadata
Title
Houttuynia cordata aqueous extract attenuated glycative and oxidative stress in heart and kidney of diabetic mice
Authors
Cheng-chin Hsu
Hui-ting Yang
Jing-jing Ho
Mei-chin Yin
Jen-ying Hsu
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 2/2016
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-015-0994-y

Other articles of this Issue 2/2016

European Journal of Nutrition 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.